BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis (Q39650937)
scientific article published on January 1, 2002
Language:
(P31) (Q13442814)
(P304) 171-177
(P407) (Q1860)
(P433) 1
(P478) 46
(P577) Tuesday, January 1, 2002
Tuesday, January 1, 2002
(P921) (Q595158)
(Q188121)
(P953) https://europepmc.org/articles/pmc126986?pdf=render
https://europepmc.org/articles/PMC126986
https://europepmc.org/articles/PMC126986?pdf=render
https://doi.org/10.1128/aac.46.1.171-177.2002
https://journals.asm.org/doi/pdf/10.1128/AAC.46.1.171-177.2002
(P1433) (Q578004)
(P1476) "BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis" (language: en)
"BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis" (language: en)
(P2093) J. M. Entenza
P. Hohl
I. Heinze-Krauss
M. P. Glauser
P. Moreillon
(P2860) (Q28361569)
(Q24550612)
(Q35124432)
(Q35823261)
(Q36328909)
(Q36753343)
(Q36752622)
(Q39779171)
(Q40431109)
(Q41265449)
(Q41696128)
(Q55067143)
(Q42283256)
(Q42278485)
(Q41611983)
(Q53973330)
(Q54105049)
(Q42545796)
(Q68198941)
(Q74716023)
other details
description scientific article published on January 1, 2002

External Links